Adcock Ingram Holdings | AIP - Zysk Brutto Na Sprzedaży



Zysk Brutto Na Sprzedaży Zmiana Data
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Aspen Pharmacare ZAR 10.14B 830M 2024-06
Avita Medical AUD 14.31M 639K 2025-12
Dianthus Therapeutics USD 284K 112K 2025-12
Ionis Pharmaceuticals USD 195M 40M 2025-12
IQVIA Holdings USD 1.12B 32M 2025-12
Life Healthcare ZAR 14.66B 1.12B 2022-12
Moderna USD 226M 583M 2025-12
Netcare ZAR 5.51B 475M 2022-12
Organon & Co USD 854M 3M 2025-12
Revvity USD 421.66M 47.06M 2025-12
Tectonic Therapeutic USD 0 0 2025-03
Viatris USD 1.15B 223.6M 2025-12
Xeris Pharmaceuticals USD 72.15M 8.77M 2025-12